ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 117 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450,000 | -73.0% | 500,000 | +46.5% | 0.05% | -68.2% |
| Q4 2022 | $5,374,514 | +0.1% | 341,239 | 0.0% | 0.15% | -3.2% |
| Q3 2022 | $5,371,000 | +12.7% | 341,239 | 0.0% | 0.16% | +4.7% |
| Q2 2022 | $4,764,000 | -27.9% | 341,239 | -11.0% | 0.15% | +12.9% |
| Q1 2022 | $6,607,000 | -70.9% | 383,239 | -75.5% | 0.13% | -24.6% |
| Q4 2021 | $22,718,000 | +61.6% | 1,562,472 | +100.0% | 0.18% | -14.2% |
| Q3 2021 | $14,062,000 | -52.9% | 781,236 | -54.0% | 0.20% | +5.2% |
| Q2 2021 | $29,852,000 | +82.2% | 1,700,000 | +161.5% | 0.19% | -6.3% |
| Q1 2021 | $16,380,000 | -56.4% | 650,000 | -48.4% | 0.21% | -90.3% |
| Q1 2017 | $37,598,000 | +9.9% | 1,260,847 | 0.0% | 2.14% | -12.0% |
| Q4 2016 | $34,219,000 | +210.7% | 1,260,847 | +193.2% | 2.43% | +242.2% |
| Q3 2016 | $11,012,000 | – | 430,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |